Copy Link Print Information

β-Amyloid (1-42), human, HFIP-treated

27 Cited Publications
Customer Review

Based on 27 publication(s) in Google Scholar

β-Amyloid (1-42), human, HFIP-treated, a 42-amino acid peptide that has been treated with HFIP from β-Amyloid (1-42), human (HY-P1363A), is a brain-penetrant amyloid protein fragment, which can be used in research on Alzheimer's disease and Down’s syndrome. β-Amyloid (1-42), human, HFIP-treated remaining as a monomer exhibits antioxidant and neuroprotective effects. β-Amyloid (1-42), human, HFIP-treated, after being dissolved in DMSO to form the stock solution, on the one hand, can form soluble oligomers (AβOs) when incubated at 4°C, which have synaptic toxicity and neurotoxicity; on the other hand, it can be incubated at 37°C to form insoluble fibrils, with lower neurotoxicity, and participating in the oxidative damage process. Aβ42 oligomers bind to various neuronal surface receptors (such as PrPc, mGluR5, NMDA receptors, etc.), triggering oxidative stress, calcium homeostasis imbalance, and synaptic toxicity via activating downstream signaling pathways, leading to neuronal dysfunction and death.

For research use only. We do not sell to patients.

  • Purity: 98.41%
  • CAS No.: 107761-42-2
  • Formula: C203H311N55O60S
  • Molecular Weight:4514.04
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • β-Amyloid (1-42), human, HFIP-treated Chemical Structure
    β-Amyloid (1-42), human, HFIP-treated Chemical Structure
  • Experimental Validation Results for β-Amyloid (1-42), human, HFIP-treated
  • Experimental Validation Results for β-Amyloid (1-42), human, HFIP-treated
  • Experimental Validation Results for β-Amyloid (1-42), human, HFIP-treated
  • Experimental Validation Results for β-Amyloid (1-42), human, HFIP-treated
  • Experimental Validation Results for β-Amyloid (1-42), human, HFIP-treated
  • Experimental Validation Results for β-Amyloid (1-42), human, HFIP-treated
CAS No.: 107761-42-2
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of β-Amyloid (1-42), human, HFIP-treated:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) β-Amyloid (1-42), human, HFIP-treated

More
Customer Validation & Images
WBCell Proliferation/Viability AssayIFRT-PCR
  • WB
  • Cell Proliferation/Viability Assay
  • IF
  • RT-PCR
  • WB
  • RT-PCR
Keywords
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • β-Amyloid (1-42), human, HFIP-treated Chemical Structure
    β-Amyloid (1-42), human, HFIP-treated Chemical Structure
    1/16
  • 1/16

    β-Amyloid (1-42), human, HFIP-treated purchased from MedChemExpress. Usage Cited in: J Neuroinflammation. 2024 Dec 23;21(1):327. [Abstract]

    Customer Validation
     Protein levels in BV2 cell treated with or without BCAAs/ BCKAs for 4 h in the presence of Aβ (1 μM) and the corresponding quantification results (n = 3).

  • 1/16

    β-Amyloid (1-42), human, HFIP-treated purchased from MedChemExpress. Usage Cited in: Biomed Pharmacother. 2024 Sep:178:117199. [Abstract]

    Customer Validation
     The effect of NMN on the survival rate of β-Amyloid (1-42) (Aβ, 1 μM; 24 h)-induced PC12 cells was determined by MTT assay.

  • 1/16

    β-Amyloid (1-42), human, HFIP-treated purchased from MedChemExpress. Usage Cited in: Front Aging Neurosci. 2022 Apr 25;14:890134. [Abstract]

    Customer Validation
     Immunofluorescence showed lost ARC expression after 10 μM Aβ treatment. For Aβ treatment, human β-Amyloid (1-42) (HY-P1363) was dissolved, and the solution was incubated for 3 days at 37°C to form oligomeric Aβ, and then cells were treated with 10 μM Aβ for 48 h.

  • 1/16

    β-Amyloid (1-42), human, HFIP-treated purchased from MedChemExpress. Usage Cited in: Front Aging Neurosci. 2022 Apr 25;14:890134. [Abstract]

    Customer Validation
     qRT-PCR showed decreased mRNA levels of ARC after 10 μM Aβ treatment (n = 3). For Aβ treatment, human β-Amyloid (1-42) (HY-P1363) was dissolved, and the solution was incubated for 3 days at 37°C to form oligomeric Aβ, and then cells were treated with 10 μM Aβ for 48 h.

  • 1/16

    β-Amyloid (1-42), human, HFIP-treated purchased from MedChemExpress. Usage Cited in: Front Aging Neurosci. 2022 Apr 25;14:890134. [Abstract]

    Customer Validation
     Western blotting analysis showed declined protein levels of ARC after 10 μM Aβ treatment (n = 3). For Aβ treatment, human β-Amyloid (1-42) (HY-P1363) was dissolved, and the solution was incubated for 3 days at 37°C to form oligomeric Aβ, and then cells were treated with 10 μM Aβ for 48 h.

  • 1/16

    β-Amyloid (1-42), human, HFIP-treated purchased from MedChemExpress. Usage Cited in: Aging. 2021 Jun 9;13(11):15569-15579. [Abstract]

    Customer Validation
     10 μM Aβ increased the mRNA expression of GRIA1 and GRIN2A, and decreased GRIN1 mRNA expression. n = 3. For the Aβ treatment, cells were incubated with 10 μM human β-Amyloid (1-42) for 48 h.

  • β-Amyloid (1-42), human, HFIP-treated